Bank of America started coverage on shares of Reneo Pharmaceuticals (NASDAQ:RPHM – Free Report) in a research note released on Monday, Marketbeat Ratings reports. The firm issued a buy rating on the stock. Reneo Pharmaceuticals Price Performance Shares of Reneo Pharmaceuticals stock opened at $6.79 on Monday. Reneo Pharmaceuticals has a 52-week low of $1.79 […]
Bank of America began coverage on shares of Reneo Pharmaceuticals (NASDAQ:RPHM – Free Report) in a research note released on Monday, The Fly reports. The firm issued a buy rating on the stock. Reneo Pharmaceuticals Stock Performance NASDAQ:RPHM opened at $6.79 on Monday. Reneo Pharmaceuticals has a fifty-two week low of $1.79 and a fifty-two […]
Analysts at Bank of America began coverage on shares of Reneo Pharmaceuticals (NASDAQ:RPHM – Free Report) in a report released on Monday, The Fly reports. The brokerage set a “buy” rating on the stock. Reneo Pharmaceuticals Price Performance RPHM opened at $6.41 on Monday. The business has a fifty day simple moving average of $8.15 […]
Shares of Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM – Get Rating) shot up 1% during mid-day trading on Friday . The company traded as high as $9.30 and last traded at $8.93. 87,418 shares were traded during mid-day trading, an increase of 3% from the average session volume of 84,853 shares. The stock had previously closed at […]
Reneo Pharmaceuticals, Inc. (NASDAQ:RPHM – Get Rating) Director Niall O’donnell purchased 125,000 shares of the firm’s stock in a transaction that occurred on Monday, May 8th. The shares were bought at an average cost of $8.00 per share, for a total transaction of $1,000,000.00. Following the completion of the acquisition, the director now directly owns […]